13F Insight
DOSSIER · 13F-HR · Q2 2026

APEIRON CAPITAL Ltd

$156M in tracked AUM across 14 positions as of Q2 2026.

AC
CIK 0001843111 · last filed Jun 30, 2026
Total AUM
$156M
as of Q2 2026
Holdings
14
—
positions
Whale Score
69
69
tracked
Activity
—
no data
changes this Q
AI Analysis · Q2 2026
Comprehensive Analysis of APEIRON CAPITAL Ltd 13F Filing (Q3 2025)
Portfolio Overview

APEIRON CAPITAL Ltd has reported a significant expansion in its portfolio management activities for the quarter ending September 30, 2025. The total portfolio value surged by 76.9%, increasing from $105.93M to $187.41M. This substantial growth in assets under management (AUM) is driven not only by market performance but likely by significant capital inflows or aggressive repositioning, evidenc...

Key Holdings

The portfolio is dominated by leveraged and high-growth exposures, with the GraniteShares 2x Long NVDA Daily ETF (NVDL) serving as the cornerstone holding. Valued at $88.00M, this position constitutes 46.96% of the entire portfolio. This indicates a massive, leveraged bet on the continued performance of NVIDIA, effectively doubling the exposure to the underlying stock's daily price movements.

The second-largest holding is ON Holding AG (ONON) at $33.70M (17.98%), suggesting a strong conviction in the consumer discretionary and athletic apparel space. The third and fourth positions, Summit Therapeutics (SMMT) at $27.08M (14.45%) and Qifu Technology (QFIN) at $22.84M (12.18%), represent significant high-beta plays in healthcare and financial services, respectively.

Analysis generated by 13F Insight from SEC Form 13F filing data · Q2 2026. Methodology

Quarter at a glance — Q2 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q2 2026.

#HoldingValueSharesWeight
01
MUU
DIREXION DAILY MU BULL 2X ET
$36M34K22.9%02
H5919C104
ON HOLDING AG-CLASS A
$28M796K18.1%03
ABVX
ABIVAX SA-ADR
$17M131K11.2%04
QFIN
QFIN HOLDINGS INC-ADR
$15M976K9.9%05
SMMT
SUMMIT THERAPEUTICS INC
$14M962K9.0%06
TSM
TAIWAN SEMICONDUCTOR-SP ADR
$9M18K5.5%07
WDC
WESTERN DIGITAL CORP
$8M13K5.3%08
NKTR
NEKTAR THERAPEUTICS
$7M106K4.8%09
NOK
NOKIA CORP-SPON ADR
$5M379K3.2%10
G7997R103
SEAGATE TECHNOLOGY HOLDINGS
$5M5K3.1%

Filing history

2026Q2Jun 30
$156M▲ 45.6%
14 positionsView →2026Q1Mar 31
$107M▲ 23.6%
13 positionsView →2025Q4Dec 31
$86M▼ 53.9%
5 positionsView →2025Q3Sep 30
$187M▲ 76.9%
7 positionsLocked2025Q2Jun 30
$106M▼ 44.7%
5 positionsLocked2025Q1Mar 31
$192M▼ 28.6%
8 positionsLocked2024Q4Dec 31
$268M▼ 4.3%
13 positionsLocked2024Q3Sep 30
$280M▼ 2.2%
10 positionsLocked2024Q2Jun 30
$287M▲ 44.8%
11 positionsLocked2024Q1Mar 31
$198M▲ 190.8%
12 positionsLocked2023Q4Dec 31
$68M▼ 54.5%
8 positionsLocked2023Q3Sep 30
$149M▼ 9.7%
11 positionsLocked
Showing 12 of 23